GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Atricure, Inc. (ATRC) [hlAlert]

Rating:
Buy ATRC
up 425.40 %

Atricure, Inc. (ATRC) rated Buy with price target $7 by Maxim Group

Posted on: Wednesday,  Jun 9, 2010  8:25 AM ET by Maxim Group

Maxim Group rated Buy Atricure, Inc. (NASDAQ: ATRC) on 06/09/2010, when the stock price was $5.00. Since
then, Atricure, Inc. has gained 425.40% as of 01/06/2016's recent price of $26.27.
If you would have followed this Maxim Group's recommendation on ATRC, you would have gained 425.4% of your investment in 2037 days.

AtriCure, Inc. is a medical device company that develops, manufactures and sells cardiac surgical ablation systems designed to create precise lesions, or scars, in cardiac, or heart, tissue. The Company's primary product line, which accounts for a majority of its revenues, is the AtriCure Isolator system. AtriCure's Isolator system consists primarily of a compact power generator known as an ablation and sensing unit (ASU), a switchbox unit (ASB), which allows physicians to toggle between multiple products and multiple configurations of its Isolator clamps, including its Isolator Synergy clamps. AtriCure also sells a multifunctional bipolar pen, or multifunctional pen, which is often used by physicians in combination with its Isolator system to ablate cardiac tissue and for temporary pacing, sensing, stimulating and recording during the evaluation of cardiac arrhythmias. In 2008, The Company received FDA approval for its EXCLUDE clinical trial.

At Maxim Group, our vision for equity research is to be a client’s first call for value-added research on companies not widely followed by Wall Street. Maxim’s premier niche is emerging-growth companies in a variety of sectors, including healthcare, technology, retail and others. As strong believers in fundamental research, our analysts utilize a “bottom up” approach to making investment recommendations. We combine rigorous financial analysis of specific companies and industries with due diligence that includes frequent consults with suppliers, customers, competitors and senior management. By applying these skills and techniques, we are able to offer our clients differentiated research.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/9/2010 8:25 AM Buy
None
5.00 7.00
as of 12/31/2010
1 Week up  4.78 %
1 Month up  19.59 %
3 Months up  36.46 %
1 YTD up  114.80 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy